Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and combined oral contraceptive trial for premenstrual syndrome
ACTRN12614001243606Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluoxetine, ethinyl estradiol + gestodene and Placebo-COD Research Private Ltd in premenstrual syndrome (PMS) (3 arms), sponsored by Cairo University. Primary endpoint: Change in DRSP score. Started May 2013; status: recruiting.
02
Drugs
fluoxetineethinyl estradiol + gestodenePlacebo-COD Research Private Ltd
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on ACTRN12614001243606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001243606.